Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of a Novel Transcatheter Anti-embolic Filter (FLOWer) for Cerebral Protection During Aortic Valve Interventions

NCT04704258 is registered in ClinicalTrials.gov with AorticLab Srl as lead sponsor.

NCT NCT04704258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04704258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of a Novel Transcatheter Anti-embolic Filter (FLOWer) for Cerebral Protection During Aortic Valve Interventions
Lead sponsor
AorticLab Srl
Phase
Not applicable
Overall status
Completed
Start date
May 3, 2021
Completion date
June 6, 2023
Enrollment
100 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis, intracranial embolism and thrombosis